Theodore J. Witek, Theravance's Sr. VP & Chief Scientific Off., recently disposed of 3,089 shares of the company. The disposals took place at $14.59 per share, on May 20, 2018. Witek still owns 259,360 shares of the company. Witek operates out of Brisbane, CA. Some additional info was provided as follows:
The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
Includes 432 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2018.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!